11-4587363-T-C
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_001005170.4(OR52I2):āc.473T>Cā(p.Ile158Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000658 in 1,459,064 control chromosomes in the GnomAD database, including 28 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Consequence
NM_001005170.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR52I2 | NM_001005170.4 | c.473T>C | p.Ile158Thr | missense_variant | 1/1 | NP_001005170.2 | ||
OR52I2 | NM_001405760.1 | c.473T>C | p.Ile158Thr | missense_variant | 2/2 | NP_001392689.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR52I2 | ENST00000641896.1 | c.473T>C | p.Ile158Thr | missense_variant | 2/2 | ENSP00000493402.1 | ||||
OR52I2 | ENST00000641486.1 | c.473T>C | p.Ile158Thr | missense_variant | 1/1 | ENSP00000493314.1 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 86AN: 147410Hom.: 1 Cov.: 33 FAILED QC
GnomAD3 exomes AF: 0.0000358 AC: 9AN: 251158Hom.: 2 AF XY: 0.0000589 AC XY: 8AN XY: 135758
GnomAD4 exome AF: 0.0000658 AC: 96AN: 1459064Hom.: 28 Cov.: 33 AF XY: 0.0000689 AC XY: 50AN XY: 726016
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.000583 AC: 86AN: 147522Hom.: 1 Cov.: 33 AF XY: 0.000568 AC XY: 41AN XY: 72242
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 01, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Dec 01, 2022 | OR52I2: BP4, BS2 - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at